WalfordJ.FesselMD

PubMed

• 5 citations
  Virological Failure and Acquired Genotypic Resistance Associated With Contemporary Antiretroviral Treatment Regimens
  Soo-Yon Rhee, Dana S. Clutter, C. Bradley Hare, Christophe Toukam Tchakoute, Kristin L. Sainani, W. Jeffrey Fessel, Leo B. Hurley, Sally Slome, Benjamin A. Pinsky, Mic...> ;Open Forum Infectious Diseases. 2020 Sep 1
• 37 citations
  Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted Human Immunodeficiency Virus Type 1 Drug Resistance in a Large US Clinic Population.
  Soo-Yon Rhee, Dana S. Clutter, W. Jeffrey Fessel, Daniel B. Klein, Sally Slome, Benjamin A. Pinsky, Julia L. Marcus, Leo B. Hurley, Michael J. Silverberg, Sergei L Kos...> ;Clinical Infectious Diseases. 2019 Jan 7
• 6 citations
  Evolution of gag and gp41 in Patients Receiving Ritonavir-Boosted Protease Inhibitors.
  Justen Manasa, Vici Varghese, Sergei L Kosakovsky Pond, Soo-Yon Rhee, Philip L Tzou, W. Jeffrey Fessel, Karen S. Jang, Elizabeth White, Thorsteinn Rögnvaldsson, David ...> ;Scientific Reports. 2017 Sep 14
• 22 citations
  Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1-Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing.
  Dana S. Clutter, Shuntai Zhou, Vici Varghese, Soo-Yon Rhee, Benjamin A. Pinsky, W. Jeffrey Fessel, Daniel B. Klein, Ean Spielvogel, Susan Holmes, Leo B. Hurley, Michae...> ;The Journal of Infectious Diseases. 2017 Aug 1
• 18 citations
  Concordance of Several Subcellular Interactions Initiates Alzheimer's Dementia: Their Reversal Requires Combination Treatment.
  W J Fessel> ;American Journal of Alzheimer's Disease and Other Dementias. 2017 Mar 17
• 1 citations
  Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase...
  Mark S. Sulkowski, Walford J. Fessel, Adriano Lazzarin, Juan Berenguer, Natalia Zakharova, Hugo Cheinquer, Pierre Côté, Douglas T. Dieterich, Adrián Gadano, Gail V. Ma...> ;Hepatology International. 2017 Feb 16
• 119 citations
  Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
  Anna S. Lok, Calvin Q. Pan, Steven Han, Huy N. Trinh, W. Jeffrey Fessel, Timothy C. Rodell, Benedetta Massetto, Lanjia Lin, Anuj Gaggar, G. Mani Subramanian, John G. M...> ;Journal of Hepatology. 2016 Sep 1
• 9 citations
  Response to Therapy in Antiretroviral Therapy-Naive Patients With Isolated Nonnucleoside Reverse Transcriptase Inhibitor-Associated Transmitted Drug Resistance.
  Dana S. Clutter, W. Jeffrey Fessel, Soo-Yon Rhee, Leo B. Hurley, Daniel B. Klein, John P. A. Ioannidis, Michael J. Silverberg, Robert W. Shafer> ;Journal of Acquired Immune Deficiency Syndromes. 2016 Jun 1
• 204 citations
  Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.
  Mark S. Sulkowski, Susanna Naggie, Jacob Lalezari, Walford Jeffrey Fessel, Karam Mounzer, Margaret C. Shuhart, Anne F Luetkemeyer, David M. Asmuth, Anuj Gaggar, Liyun ...> ;JAMA. 2014 Jul 23
• 80 citations
  Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
  George L. Melikian, Soo-Yon Rhee, Vici Varghese, Danielle Porter, Kirsten L. White, Jonathan Taylor, William J. Towner, Paolo Troia, Jeffrey Burack, Edwin DeJesus, Gre...> ;The Journal of Antimicrobial Chemotherapy. 2014 Jan 1
• 22 citations
  Prototypical Recombinant Multi-Protease-Inhibitor-Resistant Infectious Molecular Clones of Human Immunodeficiency Virus Type 1
  Vici Varghese, Yumi Mitsuya, W. Jeffrey Fessel, Tommy F. Liu, George L. Melikian, David Katzenstein, Celia A. Schiffer, Susan Holmes, Robert W. Shafer> ;Antimicrobial Agents and Chemotherapy. 2013 Sep 1
• 9 citations
  Collinearity of protease mutations in HIV-1 samples with high-level protease inhibitor class resistance
  Farbod Babrzadeh, Vici Varghese, Mary E. Pacold, Tommy F. Liu, Pål Nyrén, Celia A. Schiffer, W. Jeffrey Fessel, Robert W. Shafer> ;The Journal of Antimicrobial Chemotherapy. 2013 Feb 1
• 15 citations
  Panel of Prototypical Recombinant Infectious Molecular Clones Resistant to Nevirapine, Efavirenz, Etravirine, and Rilpivirine
  Maya Balamane, Vici Varghese, George L. Melikian, W. Jeffrey Fessel, David Katzenstein, Robert W. Shafer> ;Antimicrobial Agents and Chemotherapy. 2012 Aug 1
• 2 citations
  Standardized representation, visualization and searchable repository of antiretroviral treatment-change episodes
  Soo-Yon Rhee, José Luis Santiago Blanco, Tommy F. Liu, Iñaki Pere, Rolf Kaiser, Maurizio Zazzi, Francesca Incardona, William J. Towner, Josep M. Gatell, Andrea De Luca...> ;AIDS Research and Therapy. 2012 May 3
• 45 citations
  Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase (RT) Mutations on Nucleoside RT Inhibitor Susceptibility
  George L. Melikian, Soo-Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William J. Towner, Paolo Troia-Cancio, Andrew R. Zolopa, Gregory K. Robbins, Ron M...> ;Antimicrobial Agents and Chemotherapy. 2012 May 1
• 22 citations
  The efficacy of an anti-CD4 monoclonal antibody for HIV-1 treatment
  W. Jeffrey Fessel, Brooke Anderson, Stephen Follansbee, Mark A. Winters, Stanley Lewis, Steven Weinheimer, Christos J. Petropoulos, Robert W. Shafer> ;Antiviral Research. 2011 Dec 1
• 14 citations
  Association of osteonecrosis and osteoporosis in HIV-1-infected patients.
  W. Jeffrey Fessel, Quyen Chau, Davis Leong> ;AIDS. 2011 Sep 24
• 24 citations
  Cryptococcosis: the 1981-2000 epidemic
  Gary D. Friedman, W. Jeffrey Fessel, Natalia Udaltsova, Leo B. Hurley> ;Mycoses. 2005 Mar 1
• 7 citations
  A new approach to an AIDS vaccine: creating antibodies to HIV vif will enable apobec3G to turn HIV-infection into a benign problem.
  W. Jeffrey Fessel> ;Medical Hypotheses. 2005 Jan 1
• 59 citations
  Once Weekly Azithromycin Therapy for Prevention of Mycobacterium avium Complex Infection in Patients with AIDS: A Randomized, Double-Blind, Placebo-Controlled Multicen...
  Edward C Oldfield, W. Jeffrey Fessel, Michael W. Dunne, Gordon M. Dickinson, Mark R. Wallace, William Byrne, Raymond T. Chung, Kenneth F. Wagner, Scott F. Paparello, D...> ;Clinical Infectious Diseases. 1998 Mar 1
• 1 citations
  Association of osteonecrosis and peripheral neuropathy in HIV-1-infected patients: possible roles of nerve growth factor and vascular endothelial growth factor.
  W. Jeffrey Fessel, Quyen Chau, Davis Leong> ;AIDS. 2011 Nov 28
• 27 citations
  HIV-1 Integrase Sequence Variability in Antiretroviral Naïve Patients and in Triple-Class Experienced Patients Subsequently Treated with Raltegravir
  Vici Varghese, Tommy F. Liu, Soo-Yon Rhee, Paolo Libiran, Christina Trevino, W. Jeffrey Fessel, Robert W. Shafer> ;AIDS Research and Human Retroviruses. 2010 Dec 10
• 143 citations
  HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
  Soo-Yon Rhee, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William J. Towner, Paolo Troia, Peter Ruane, James Hellinger, Vivian Shirvani, Andrew R. Zolopa, Rober...> ;Antimicrobial Agents and Chemotherapy. 2010 Oct 1
• 51 citations
  Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation.
  Vici Varghese, Elijah Wang, Farbod Babrzadeh, Michael Bachmann, Rajin Shahriar, Tommy F. Liu, Svetlana Jean M. Mappala, Baback Gharizadeh, W. Jeffrey Fessel, David Kat...> ;Plos One. 2010 Jun 7
• 24 citations
  Panel of Prototypical Raltegravir-Resistant Infectious Molecular Clones in a Novel Integrase-Deleted Cloning Vector
  Elizabeth C. Reuman, Michael Bachmann, Vici Varghese, W. Jeffrey Fessel, Robert W. Shafer> ;Antimicrobial Agents and Chemotherapy. 2010 Feb 1
• Join now to see all